Literature DB >> 24906790

Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms.

Brisa Solé1, C Mar Bonnin1, María Mayoral2, Benedikt L Amann3, Imma Torres1, Ana González-Pinto4, Esther Jimenez1, Jose Manuel Crespo5, Francesc Colom1, Rafael Tabarés-Seisdedos6, Maria Reinares1, Jose Luis Ayuso-Mateos7, Sara Soria8, M Paz Garcia-Portilla9, Ángela Ibañez10, Eduard Vieta11, Anabel Martinez-Aran12, Carla Torrent1.   

Abstract

Recently, Functional Remediation (FR) has proven to be effective in improving the functional outcome of euthymic bipolar patients. The aim of this study was to test the efficacy of the FR program in a subsample of euthymic bipolar II patients (BPII). A post-hoc analyses were undertaken using data of 53 BPII outpatients who had participated in a multicenter, rater-blind, randomized, controlled trial exploring the efficacy of FR (n=17) as compared with a Psychoeducation group (PSY) (n=19) and a treatment as usual control group (TAU n=17). The primary outcome variable was the functional improvement defined as the mean change in the Functioning Assessment Short Test (FAST) from baseline to endpoint after the intervention. Regarding the treatment effect, data reveal a significant functional improvement from baseline to endpoint, suggestive for an interaction between program pertinence and time (pre-post). Nevertheless, Tukey׳s post-hoc test only revealed a trend in favor of a better outcome for FR when compared to the other two groups. We also found an interaction between program pertinence and time when analysing the subdepressive symptoms, with BPII patients in FR showing a significant reduction when compared to the PSY group. Our results suggest that the FR appears to be effective in improving the overall functional outcome in BPII, as well as in reducing subdepressive symptoms.
Copyright © 2014 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Bipolar II disorder; Cognitive functioning; Cognitive impairment; Cognitive remediation; Subsyndromic depressive symptoms

Mesh:

Year:  2014        PMID: 24906790     DOI: 10.1016/j.euroneuro.2014.05.010

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  17 in total

1.  Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design.

Authors:  Katherine E Burdick; Terence A Ketter; Joseph F Goldberg; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2015-03       Impact factor: 4.384

Review 2.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

Review 3.  Treatment of Functional Impairment in Patients with Bipolar Disorder.

Authors:  Jose Sanchez-Moreno; Anabel Martinez-Aran; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

Review 4.  Cognitive remediation: potential novel brain-based treatment for bipolar disorder in children and adolescents.

Authors:  Daniel P Dickstein; Grace K Cushman; Kerri L Kim; Alexandra B Weissman; Ezra Wegbreit
Journal:  CNS Spectr       Date:  2015-08       Impact factor: 3.790

Review 5.  The difficult lives of individuals with bipolar disorder: A review of functional outcomes and their implications for treatment.

Authors:  Michael J Gitlin; David J Miklowitz
Journal:  J Affect Disord       Date:  2016-11-22       Impact factor: 4.839

6.  The effects of cognitive remediation on cognitive abilities and real-world functioning among people with bipolar disorder: A systematic review: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.

Authors:  Marcella Bellani; Bruno Biagianti; Niccolò Zovetti; Maria Gloria Rossetti; Cinzia Bressi; Cinzia Perlini; Paolo Brambilla
Journal:  J Affect Disord       Date:  2019-07-19       Impact factor: 4.839

7.  Psychosocial treatment and interventions for bipolar disorder: a systematic review.

Authors:  Stella Miziou; Eirini Tsitsipa; Stefania Moysidou; Vangelis Karavelas; Dimos Dimelis; Vagia Polyzoidou; Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2015-07-07       Impact factor: 3.455

8.  The Cognitive Remediation in Bipolar (CRiB) pilot study: study protocol for a randomised controlled trial.

Authors:  Rebecca Strawbridge; Jessica Fish; Rozmin Halari; John Hodsoll; Clare Reeder; Karine Macritchie; Paul McCrone; Til Wykes; Allan H Young
Journal:  Trials       Date:  2016-07-29       Impact factor: 2.279

9.  Brain Structure and Function in Women with Comorbid Bipolar and Premenstrual Dysphoric Disorder.

Authors:  Sabrina K Syan; Luciano Minuzzi; Mara Smith; Dustin Costescu; Olivia R Allega; Geoffrey B C Hall; Benicio N Frey
Journal:  Front Psychiatry       Date:  2018-01-10       Impact factor: 4.157

Review 10.  Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.

Authors:  Brisa Solé; Esther Jiménez; Carla Torrent; Maria Reinares; Caterina Del Mar Bonnin; Imma Torres; Cristina Varo; Iria Grande; Elia Valls; Estela Salagre; Jose Sanchez-Moreno; Anabel Martinez-Aran; André F Carvalho; Eduard Vieta
Journal:  Int J Neuropsychopharmacol       Date:  2017-08-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.